Role of the IGF-I receptor in the regulation of cell-cell adhesion: implications in cancer development and progression.
about
Gene expression profiling of epithelial ovarian tumours correlated with malignant potentialCross-Talk between Adiponectin and IGF-IR in Breast CancerIGF-1 Receptor and Adhesion Signaling: An Important Axis in Determining Cancer Cell Phenotype and Therapy ResistanceTargeting highly expressed extracellular HSP90 in breast cancer stem cells inhibits tumor growth in vitro and in vivo.Will targeting insulin growth factor help us or hurt us?: An oncologist's perspectiveIGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer.LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis.Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor.Insulin and cancer.Expression of nuclear insulin receptor substrate 1 in breast cancer.The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells.The insulin-like growth factor-I receptor as a target for cancer therapy.Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system.Clinical significance of insulin-like growth factor-1 receptor expression in stage I non-small-cell lung cancer: immunohistochemical analysisA randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer.Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy.The role of the insulin‑like growth factor (IGF) axis in osteogenic and odontogenic differentiation.MicroRNA-100 regulates IGF1-receptor expression in metastatic pancreatic cancer cells.Cellular distribution of the IGF-1R in corneal epithelial cells.Inhibition of IGF-1 signaling by genistein: modulation of E-cadherin expression and downregulation of β-catenin signaling in hormone refractory PC-3 prostate cancer cells.Heme-binding protein HRG-1 is induced by insulin-like growth factor I and associates with the vacuolar H+-ATPase to control endosomal pH and receptor trafficking.Stat3 is required for full neoplastic transformation by the Simian Virus 40 large tumor antigen.Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells.A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells.Insulin-like growth factor-1 signaling is responsible for cathepsin G-induced aggregation of breast cancer MCF-7 cellsExpression of insulin-like growth factor-I receptor in primary cutaneous carcinomas.The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.Tumor necrosis factor alpha inhibits cyclin A expression and retinoblastoma hyperphosphorylation triggered by insulin-like growth factor-I induction of new E2F-1 synthesis.Autocrine production of insulin-like growth factor-I (IGF-I) affects paracellular transport across epithelial cells in vitro.IGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas.IRS1/β-Catenin Axis Is Activated and Induces MYC Expression in Acute Lymphoblastic Leukemia Cells.Long-term exposure to carcinoma-associated fibroblasts makes breast cancer cells addictive to integrin β1.
P2860
Q24805553-394A0138-DD1D-444E-9062-DC8163C217C4Q26799865-16B870F7-BC97-419B-9529-62F6FC6DE241Q26802042-CC1E4A22-690D-4B80-B3CC-4AB5F4375DACQ30805174-A8FE25ED-FF00-44EC-9607-DBC8FECC432EQ33926307-E4FADD81-6DB2-4209-8ABE-F58A88DD114BQ34958659-6E0BF7C0-3CBA-409D-8C17-7274643160D8Q35221829-BFDFD384-3318-4AAC-81A5-B0CD61E3B3EBQ35551142-761DC638-FE28-4030-B068-5180C826C008Q35624527-33D93C20-9B5D-4DD9-AFF9-9C88D1EAE6C9Q35954427-CDA960A5-9320-40AF-BA60-528834876D07Q35973076-60ED7216-2558-4FC7-BAB3-6870093421E9Q36219706-61DA6703-EF05-423E-8E94-45EEC84A6F32Q36287335-87694D42-533E-45F5-94FC-2F09BB7371DAQ37203589-5469ED2A-E047-48FF-85BD-B92556E45554Q37258981-EA053DEB-2880-42B1-8931-1C652B0A9913Q37975246-4CBB43EF-9B81-421C-AB62-DF13236041BBQ38162713-392D9F8E-839D-450A-AB58-38B0D6206970Q39201000-CFD576C6-C659-4D60-867C-A656728BE627Q39423719-C686E61E-ACAB-4283-9451-6B113BA3DCBAQ39440714-0452C01E-660B-4202-ADC4-90B5D0FE21F3Q39781832-DA05949A-5FE0-4324-BB19-138760200062Q40417149-EE96495F-707D-45F4-A6CE-C0325908BC29Q40580990-6EE56D89-D543-46A9-BFD5-31EA6F60FFCBQ40616617-CF6F990A-A6A0-48AF-91BF-D1677E795C72Q41247922-28D28306-0AF8-43B8-8642-AAFE0455D374Q42459590-B4A0FA2D-70FB-4118-97BB-5FDED8670FAEQ43241596-74055D90-BAD9-4F4E-BCCE-2DA08108A887Q44697384-15F24884-9520-439B-B4F5-09E880DED218Q44931253-9816D68D-A3E9-458F-BB7E-9C6EC132DAB8Q46676464-5176A366-E581-4FF8-96BF-64106F840C44Q48143888-3C0AAF07-ECDB-4727-A408-4024B95203E1Q55167166-7F4B9D64-FE58-49D7-B46F-76BBC1C01085
P2860
Role of the IGF-I receptor in the regulation of cell-cell adhesion: implications in cancer development and progression.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Role of the IGF-I receptor in ...... r development and progression.
@ast
Role of the IGF-I receptor in ...... r development and progression.
@en
type
label
Role of the IGF-I receptor in ...... r development and progression.
@ast
Role of the IGF-I receptor in ...... r development and progression.
@en
prefLabel
Role of the IGF-I receptor in ...... r development and progression.
@ast
Role of the IGF-I receptor in ...... r development and progression.
@en
P2093
P356
P1476
Role of the IGF-I receptor in ...... r development and progression.
@en
P2093
Eva Surmacz
Loredana Mauro
Marc E Bracke
Michele Salerno
Tom Boterberg
P304
P356
10.1002/JCP.10207
P577
2003-02-01T00:00:00Z